Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MEDTRONIC R&D DIABETES DENMARK A/S
A/S
Dissolved
CVR 21512001
Arne Jacobsens Allé 17, 2300
København S
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1999
1 employees
Watchlist
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
MEDTRONIC R&D DIABETES DENMARK A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (8)
SM
Susanne Mariegaard
Management
Management
1999 – 2003
SS
Steven Swinson
Management
Management
2009 – 2010
KB
Karl-Alfred Brylle
Audit
Audit
1999 – 1999
VC
Victor Christoffersen
Management
Management
1999 – 1999
JH
Johannes Henricus Wilhelmus Marie Wijnands
Management
Management
2005 – 2009
BS
Bengt Steinar Holmström
Management
Management
2003 – 2004
EG
Erich Groesslinger
Management
Management
2004 – 2009
MS
Mette-Marie Sonne Harild
Management
Management
2010 – 2017
Board of directors
Non-executive oversight
Name
Role
Member since
Former (15)
TS
Timo Schiffhauer
Chairman
2010 – 2012
JW
Jozef Willem Merkun
Board of Directors
2010 – 2010
RJ
Robert Johannes Wolhelmus ten Hoedt
Chairman
2001 – 2009
JC
Jacobus Christiaan van der Vorst
Chairman
2009 – 2010
RL
Robert L Ryan
Board of Directors
1999 – 2001
SB
Sebastian Benjamin Bahn Christoffersen
Board of Directors
1999 – 1999
AD
Arthur D Collins Jr
Chairman
1999 – 2001
SD
Stanton Dean Myrum
Board of Directors
2001 – 2003
HM
Helen Mimi Janniche
Board of Directors
1999 – 1999
BK
Birgit Kirstine Ölmestig
Board of Directors
2010 – 2011
RT
Roberto Thomas Lacentra
Board of Directors
2012 – 2012
JG
Jesper Groth-Andersen
Board of Directors
2005 – 2009
MG
Marianne Gynde
Board of Directors
2009 – 2017
JJ
Jacobus Johannes Hubregtse
Board of Directors
2003 – 2009
KA
Knud Andersen
Board of Directors
1999 – 2001
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
MEDTRONIC DANMARK A/S
Company
100%
100%
1999
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on MEDTRONIC R&D DIABETES DENMARK A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network